AVIR
Atea Pharmaceuticals Inc

3,066
Mkt Cap
$317.98M
Volume
534,868.00
52W High
$4.34
52W Low
$2.46
PE Ratio
-2.30
AVIR Fundamentals
Price
$4.08
Prev Close
$4.07
Open
$4.06
50D MA
$3.42
Beta
0.83
Avg. Volume
500,662.55
EPS (Annual)
-$2.00
P/B
1.01
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Atea Pharmaceuticals Highlights Phase 3 HCV Timeline, Unveils New Hepatitis E Candidate AT-587 at JPMorgan Conference
Atea Pharmaceuticals (NASDAQ:AVIR) used its presentation at the 44th Annual JPMorgan Healthcare Conference to provide updates on its global Phase 3 program for hepatitis C (HCV) and to outline early...
MarketBeat·19d ago
News Placeholder
More News
News Placeholder
Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.4% - Here's What Happened
Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 1.4% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Atea Pharmaceuticals (NASDAQ:AVIR) Trading Down 1.9% - Should You Sell?
Atea Pharmaceuticals (NASDAQ:AVIR) Stock Price Down 1.9% - Should You Sell...
MarketBeat·2mo ago
News Placeholder
Atea Pharmaceuticals (NASDAQ:AVIR) Releases Earnings Results, Misses Estimates By $0.07 EPS
Atea Pharmaceuticals (NASDAQ:AVIR - Get Free Report) released its quarterly earnings data on Wednesday. The company reported ($0.53) earnings per share (EPS) for the quarter, missing analysts...
MarketBeat·3mo ago
News Placeholder
Atea Pharmaceuticals Earnings Preview
read more...
Benzinga·3mo ago
<
...
1
>

Latest AVIR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.